Detalhe da pesquisa
1.
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.
Curr Rheumatol Rep
; 19(6): 37, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28623625